Admission Date:  [**2175-9-3**]     Discharge Date:  [**2175-9-18**]  Date of Birth:   [**2120-9-9**]     Sex:  F  Service:  Gynecology/Oncology  HISTORY OF PRESENT ILLNESS:  The patient is a 54-year-old gravida 2 para 2 with a history of stage IIIB cervical cancer who presented for a total pelvic exenteration secondary to cancer recurrence on bladder biopsy which was performed on [**2175-8-3**].
A cervical biopsy in [**2174-11-13**] showed invasive squamous cell carcinoma.
In [**2175-8-13**], the patient had brachytherapy (50 hours), On [**2175-2-25**], a CT scan showed no metastases.
On [**2175-8-10**], a CT scan showed no metastases; therefore, it appeared that the patient had an isolated central pelvic recurrence.
At that point, the treatment options were discussed with the patient and that total pelvic exenteration would be the curative option at this point.
PAST MEDICAL HISTORY:  In [**2164-3-15**] the patient was diagnosed with melanoma of her right posterior calf, stage [**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] level 4.
On pelvic examination, the vulva and vagina had extensive radiation affect.
There was no obvious tumor on bimanual, and rectovaginal examination revealed smooth vaginal walls and smooth rectal mucosa.
Complete blood count and Chem-10 were sent.
The patient's preoperative hematocrit was 31.5.
Her creatinine was 1.2; however, her baseline creatinine was 1.1 to 1.4.
The rest of the preoperative laboratories were within normal limits.
Intraoperative the patient received 15 liters of intravenous fluids, 12 units of packed red blood cells, 7 units fresh frozen plasma, 6 packs of platelets, 100 cc albumin, 1000 cc of hespan.
Estimated blood loss was 5.5 liters.
Intraoperatively, the patient's hematocrit decreased to a low of 14.1.
Her platelets decreased to a low of 61, and her INR at maximum was 5.
In the Surgical Intensive Care Unit, her blood pressure was kept greater than 100 systolic and greater than 60 diastolic.
She was repleted with crystalloid as well as with blood products to keep her hematocrit greater than 25.
Her blood products including fresh frozen plasma and platelets were repleted as needed.
Coagulation panel was checked in the Medical Intensive Care Unit.
The patient was transfused as needed to keep her hematocrit greater than 25.
Chest x-ray revealed proper placement of the endotracheal tube, and there was no evidence of infiltrate.
On postoperative day three, she had a temperature to 100.6 which was likely secondary to atelectasis.
Her [**Location (un) 1661**]-[**Location (un) 1662**] output was high in the Surgical Intensive Care Unit.
Her urine output did improve after receiving blood.
Her creatinine throughout her hospital course was within her baseline range of 1.1 to 1.4.
She was started on intravenous fluid hydration in the Surgical Intensive Care Unit, and her electrolytes were followed and repleted as needed.
Nutrition laboratories were checked while the patient was on total parenteral nutrition, and there were no abnormalities.
[**Location (un) 2848**] pouch flush 60 cc of 0.25% acetic acid and normal saline via the Foley catheter q.3h.
[**First Name8 (NamePattern2) **] [**First Name8 (NamePattern2) **] [**Name8 (MD) **], M.D.
[**MD Number(1) 4871**]  Dictated By:[**Name8 (MD) 2409**]  MEDQUIST36  D:  [**2175-9-19**]  12:21 T:  [**2175-9-23**]  08:03 JOB#:  [**Job Number 32542**]
